1 – 10 of 229
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease
- Contribution to journal › Article
-
Mark
Clinical Performance of the Elecsys CSF pTau181/Aβ42 Ratio for Concordance with Tau-PET in Two Independent Cohorts
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum
- Contribution to journal › Article
-
Mark
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum
- Contribution to journal › Article
-
Mark
Personalised regional modelling predicts tau progression in the human brain
- Contribution to journal › Article
-
Mark
Longitudinal tau aggregation, atrophy, and cognitive decline in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Cell-weighted polygenic risk scores are associated with β-amyloid and tau biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Predictive Value of Plasma Biomarkers in Tau-PET Transitions
- Contribution to journal › Article
-
Mark
Plasma tau biomarkers for biological staging of Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals : implications for clinical trials
- Contribution to journal › Article
